Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0001104659-25-118872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-03 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.50 | -187.1K | 687.0K | -21% | -$280.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | J | D | 187,066 | $1.50 | 686,966 | D | — | — | (F2) Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs. |